Lupin Limited has informed the Exchange regarding a press release dated Jun 07, 2021, titled "Lupin Receives U.S. FDA Approval for Emtricitabine and Tenofovir DisoproxilFumarate Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated Jun 07, 2021, titled "Lupin Receives U.S. FDA Approval for Emtricitabine and Tenofovir DisoproxilFumarate Tablets.".